02877.HK
China Shineway Pharmaceutical Group Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 8.26
+0.85%Margins
Gross margin
72.4%
EBITDA margin
26.7%
EBIT margin
21.6%
Net margin
27.1%
FCF margin
16.3%
19.8%
Return on equity
15.6%
Return on assets
15.2%
Return on invested capital
0.56x
Asset turnover
HKD 1.4B
Cash from operations
HKD 12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026